Tubulis is a Biotech company based in Munich, Germany. It has raised $575M in total funding. Latest round: Series A.
Tubulis funding overview
Tubulis is a Biotech company based in Munich, Germany. Tubulis has raised $575M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series A announced in October 2025. The round record for Tubulis runs through 2025; nothing later has been disclosed. Investors on record include Venrock, 5AM Ventures, Abingworth, Andera Partners, Coparion, EQT Life Sciences and 9 others. 15 distinct backers are named across the disclosed rounds.
Tubulis at a glance
Total raised
$575M
Latest round
Series A
Latest round date
October 2025
Industry
Biotech
Headquarters
Munich, Germany
Notable investors
Venrock, 5AM Ventures, Abingworth, Andera Partners, Coparion, EQT Life Sciences, Frazier Healthcare Partners, Third Rock Ventures
Frequently asked about Tubulis funding
How much has Tubulis raised?
Tubulis has raised $575M in total disclosed funding across the rounds on record.
Who has invested in Tubulis?
Venrock, 5AM Ventures, Abingworth, Andera Partners, Coparion, EQT Life Sciences are named among the investors backing Tubulis.
What was the latest Tubulis funding round?
The most recent disclosed round is a Series A, announced in October 2025.
Where is Tubulis based?
Tubulis is based in Munich, Germany.
What sector does Tubulis operate in?
Tubulis is tracked under Biotech from Munich, Germany, with $575M in disclosed funding.
When did Tubulis last raise?
The last disclosed Tubulis round closed in October 2025 at Series A.
Tubulis totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Munich below to benchmark round size and investor mix.
